申请人:NOVARTIS AG
公开号:WO2013093850A1
公开(公告)日:2013-06-27
The invention relates to quinoline compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein Y, W, U, Q, R1, R5 R7 and R30 are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.
本发明涉及式(I)的喹啉化合物和/或其药学上可接受的盐和/或溶剂,其中Y,W,U,Q,R1,R5,R7和R30如描述中所定义。这些化合物适用于治疗由PI3K酶活性介导的疾病或疾患。